Early Endometrial Cancer Fertility Sparing in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for early endometrial cancer fertility sparing at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
Early endometrial cancer fertility sparing — What does this stage mean?
Selected young women with Stage 1A, grade 1 endometrioid endometrial cancer who wish to preserve fertility can be offered hormonal therapy (megestrol acetate or levonorgestrel-IUD) with strict surveillance. Hysteroscopic resection of focal lesions may be combined. Complete response rate is approximately 70% over 6-12 months.
For broader information see our cancer overview and treatment page.
Recommended treatment pathway
Selected young women with Stage 1A, grade 1 endometrioid endometrial cancer who wish to preserve fertility can be offered hormonal therapy (megestrol acetate or levonorgestrel-IUD) with strict surveillance. Hysteroscopic resection of focal lesions may be combined. Complete response rate is approximately 70% over 6-12 months.
Adjuvant therapy
Definitive hysterectomy is recommended after completing family or if response is not achieved within 12 months.
Outlook
Approximately 70% achieve complete response. Pregnancy rate after response is 25-35%. Recurrence rate during follow-up is significant (25-40%); ongoing surveillance is essential.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is early endometrial cancer fertility sparing performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.
What is the likely outcome?
Approximately 70% achieve complete response. Pregnancy rate after response is 25-35%. Recurrence rate during follow-up is significant (25-40%); ongoing surveillance is essential. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is fertility preservation possible?
For selected young women with Stage 1A grade 1 disease, hormonal management with strict surveillance is offered as an alternative to surgery — see our dedicated page.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.